LEBNETE Trademark

Trademark Overview


On Wednesday, August 27, 2014, a trademark application was filed for LEBNETE with the United States Patent and Trademark Office. The USPTO has given the LEBNETE trademark a serial number of 86378038. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 22, 2022. This trademark is owned by Glaxo Group Limited. The LEBNETE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
lebnete

General Information


Serial Number86378038
Word MarkLEBNETE
Filing DateWednesday, August 27, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 22, 2022
Registration Number4825201
Registration DateTuesday, October 6, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, April 22, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 29, 2015ASSIGNED TO LIE
Thursday, May 21, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, December 10, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 10, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, December 10, 2014SUSPENSION LETTER WRITTEN
Wednesday, December 10, 2014ASSIGNED TO EXAMINER
Tuesday, September 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 30, 2014NEW APPLICATION ENTERED IN TRAM